1. Home
  2. IRIX vs RLYB Comparison

IRIX vs RLYB Comparison

Compare IRIX & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • RLYB
  • Stock Information
  • Founded
  • IRIX 1989
  • RLYB 2018
  • Country
  • IRIX United States
  • RLYB United States
  • Employees
  • IRIX N/A
  • RLYB N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • RLYB Health Care
  • Exchange
  • IRIX Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • IRIX 22.7M
  • RLYB 24.1M
  • IPO Year
  • IRIX 1996
  • RLYB 2021
  • Fundamental
  • Price
  • IRIX $1.40
  • RLYB $0.61
  • Analyst Decision
  • IRIX
  • RLYB Hold
  • Analyst Count
  • IRIX 0
  • RLYB 2
  • Target Price
  • IRIX N/A
  • RLYB N/A
  • AVG Volume (30 Days)
  • IRIX 113.5K
  • RLYB 442.0K
  • Earning Date
  • IRIX 08-12-2025
  • RLYB 11-06-2025
  • Dividend Yield
  • IRIX N/A
  • RLYB N/A
  • EPS Growth
  • IRIX N/A
  • RLYB N/A
  • EPS
  • IRIX N/A
  • RLYB N/A
  • Revenue
  • IRIX $49,744,000.00
  • RLYB $761,000.00
  • Revenue This Year
  • IRIX $9.61
  • RLYB N/A
  • Revenue Next Year
  • IRIX N/A
  • RLYB N/A
  • P/E Ratio
  • IRIX N/A
  • RLYB N/A
  • Revenue Growth
  • IRIX 0.09
  • RLYB 154.51
  • 52 Week Low
  • IRIX $0.78
  • RLYB $0.22
  • 52 Week High
  • IRIX $2.04
  • RLYB $1.24
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 60.89
  • RLYB 59.14
  • Support Level
  • IRIX $1.32
  • RLYB $0.49
  • Resistance Level
  • IRIX $1.41
  • RLYB $0.61
  • Average True Range (ATR)
  • IRIX 0.08
  • RLYB 0.05
  • MACD
  • IRIX 0.01
  • RLYB -0.00
  • Stochastic Oscillator
  • IRIX 80.56
  • RLYB 74.13

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: